Z
Zhejiang Tianyu Pharmaceutical Co Ltd
SZSE:300702
Zhejiang Tianyu Pharmaceutical Co Ltd
SZSE:300702
Price:
25.31
CNY
-0.47%
Market Cap:
¥8.8B
Relative Value
The Relative Value of one Zhejiang Tianyu Pharmaceutical Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 25.31 CNY, Zhejiang Tianyu Pharmaceutical Co Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Zhejiang Tianyu Pharmaceutical Co Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Zhejiang Tianyu Pharmaceutical Co Ltd Competitors
Zhejiang Tianyu Pharmaceutical Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
Z
|
Zhejiang Tianyu Pharmaceutical Co Ltd
SZSE:300702
|
8.8B CNY | 2.9 | 45.9 | 43.2 | 43.2 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
982.7B USD | 15.1 | 47.6 | 32.1 | 34.1 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
586.1B USD | 6.2 | 21.9 | 15.2 | 18.7 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
292.8B CHF | 4.8 | 31.1 | 13.1 | 15.3 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
240.1B GBP | 5.6 | 32.1 | 17.7 | 24.9 | |
| CH |
|
Novartis AG
SIX:NOVN
|
247.3B CHF | 5.6 | 22.7 | 14 | 17.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
302.6B USD | 4.7 | 16.6 | 10.3 | 12.1 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.5 | 13.4 | 9.8 | 11.5 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
156.1B USD | 2.5 | 20.1 | 7.5 | 10 | |
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
91B GBP | 2.8 | 16 | 8 | 11.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
